Serum Androgen Levels as a Marker for the Severity of Preeclampsia

NCT03744988 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2018-11-20

No results posted yet for this study

Summary

this study will be conducted to confirm the hypothesis of the previous studies and to list the high androgen levels as a precipitating factor for preeclampsia

Conditions

  • Severe Preeclampsia

Interventions

DIAGNOSTIC_TEST

serum androgen levels

measurement of serum free and total testosterone

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Joseph A Ibrahiem, student · Ain Shams University

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2018-06-30
Completion
2019-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03744988 on ClinicalTrials.gov